Would I Lie to You?

This week on The Bulletin, Hannah Anderson joins hosts Mike Cosper and Nicole Martin to talk about the emerging political and humanitarian crisis in Haiti, a Maryland lynching apology that’s falling flat, and the necessity truthtelling in a culture that avoids confession and repentance. Physician and New Yorker writer Dhruv Khullar stops in to talk about the new miracle weight loss drug, Ozempic -- its risks and rewards and the way it may reshape how we view weight and health for years to come.

Take our listener survey and let us know what you think of the show. 

Visit MoreCT.com/Bulletin. 

This week’s guests:

Dhruv Khullar is a contributing writer at The New Yorker, where he writes about medicine, health care, and politics. He is also a practicing physician and an assistant professor at Weill Cornell Medicine, and serves as director of the Physicians Foundation Center for the Study of Physician Practice and Leadership. His research, which focuses on value-based care, health disparities, and medical innovation, has been published in JAMA and The New England Journal of Medicine, and his writing has previously appeared in the New York Times, the Washington Post, and The Atlantic. Khullar earned his medical degree from Yale School of Medicine and completed his medical training at Massachusetts General Hospital. He also received a master’s degree in public policy from the Harvard Kennedy School, where he was a fellow at the Center for Public Leadership.

Hannah Andersen is the author of Made for More, All That’s Good, and Humble Roots: How Humility Grounds and Nourishes Your Soul.

Resources Referenced:

What Evangelicals Owe Haiti | Christianity Today

The Year of Ozempic | The New Yorker

“The Bulletin” is a production of Christianity Today

Executive Producer: Erik Petrik

Producer: Clarissa Moll and Matt Stevens

Associate Producer: McKenzie Hill

Editing and Mix: TJ Hester

Music: Dan Phelps

Show Design: Bryan Todd

Graphic Design: Amy Jones

Social Media: Kate Lucky

Learn more about your ad choices. Visit podcastchoices.com/adchoices